Cardiac Resynchronization Therapy: Current State of the Art. Cost Versus Benefit

Circulation

Volumn 109, Issue 3, 2004, Pages 300-307

  Auricchio, Angelo ^a   Abraham, William T ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATION; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; EXERCISE TEST; HEALTH CARE COST; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART RATE; HEART VENTRICLE PACING; HEART VENTRICLE REMODELING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

BUNDLE-BRANCH BLOCK; CARDIAC OUTPUT, LOW; CARDIAC PACING, ARTIFICIAL; COST-BENEFIT ANALYSIS; HUMANS; TREATMENT FAILURE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 1642580537     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000115583.20268.E1     Document Type: Short Survey

References (35)

1. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1902-1905.
2. Auricchio A, Stellbrink C, Sack S. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:2026-2033.
3. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-880.
4. Young JB, Abraham WT, Smith AL, et al. Safety and efficacy of combined cardiac resynchronization therapy and implantable cardioversion defibrillation in patients with advanced chronic heart failure. The Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) trial. JAMA. 2003;289:2685-2694.
5. Bristow MR, Feldman AM, Saxon LA, et al. Cardiac resynchronization therapy (CRT) reduces hospitalizations, and CRT with implantable defibrillator (CRT-D) reduces mortality in chronic heart failure: the COMPANION trial. Available at http://www.uchsc.edu/cvi/HFSA%20V3%20Late%20Breaker-presented%209.24.03.pdf. Accessed January 10, 2003.
6. Auricchio A, Stellbrink C, Butter C, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109-2116.
7. Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J. 2002;143:398-405.
8. Prinzen FW, Hunter WC, Wyman BT, et al. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol. 1999;33:1735-1742.
9. Ukkonen H, Beankinds RSB, Burwash IG, et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation. 2003;107:28-31.
10. The DAVID Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with implantable cardioverter-defibrillator. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288:3115-3123.
11. Kajstura J, Zhang X, Szoke E, et al. The cellular basis of pacing-induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation. 1995;92:2306-2317.
12. Spragg DD, Leclercq, Loghmani M, et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108:929-932.
13. Auricchio A, Fantoni C, Regoli F, et al. Characterization of left ventricular activation in patients with heart failure and left bundle branch block. Circulation. In press.
14. Auricchio A, Ding J, Spinelli JC, et al. Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. J Am Coll Cardiol. 2002;39:1163-1169.
15. Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation. 1997;96:3273-3277.
16. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure study group. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation. 1999;99:2993-3001.
17. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 1999;22:1567-1573.
18. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left-ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
19. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
20. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
21. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
22. Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
23. Packer M, Antonopoulos GV, Berlin JA, et al. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. Am Heart J. 2001;141:899-907.
24. Auricchio A, Spinelli JC, Trautmann SI, et al. Effect of resynchronization therapy on ventricular remodeling. J Card Fail. 2002;8:S549-S555.
25. St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure patients. Circulation. 2003;107:1985-1990.
26. Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneous delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002;105:438-445.
27. Kadhiresan VA, Pasore J, Auricchio A, et al. A novel method-the Activity Log Index-for monitoring physical activity of patients with heart failure. Am J Cardiol. 2002;89:1435-1437.
28. Adamson PB, Klockner KJ, VanHout WL, et al. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation. 2003;108:266-269.
29. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002;106:2145-2161.
30. Bentkover JD, Stewart EJ, Ignaszewski A, et al. New technologies and potential cost savings related to morbidity and mortality reduction in Class III-IV heart failure patients in Canada. Int J Cardiol. 2003;88:33-41.
31. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003;289:730-740.
32. Bantz K, Gras D. Cardiac resynchronization therapy: a model to assess the economical value of this new technology. Eur Heart J. 2003;24:364. Abstract.
33. Butter C, Auricchio A, Stellbrink C, et al. Clinical efficacy of one year cardiac resynchronization therapy in heart failure patients stratified by QRS duration: results of the PATH-CHF II trial. Eur Heart J. 2003;24:363. Abstract.
34. Achilli A, Sassara M, Ficili S, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS complex. J Am Coll Cardiol. 2003;42:2117-2124.
35. Breithard OA, Stellbrink C, Herbots L, et al. Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block. J Am Coll Cardiol. 2002;39:2026-2033.